Wall Street's Lates...
Health Care: Drugs
Galena Biopharma Inc (RXII: NASDAQ)
$1.09 -0.01 | -0.91%
02/10/12 - 03:59 PM ET
803.07K / 488.30K
Vol / Avg. Vol:1.11 / 1.10
Open / Prev. Close:1.04 - 1.13
Today's Range:0.36 - 2.14
52 Wk Range:-74.81%
Performance YTD:TheStreet Rating:
Portfolios with RXII
- Portfolio NameUser Type
- UserRAPTOR SPRTD RED CHIPS-1302...
- UserRAPTOR SPRTD RED CHIPS LIST
- Userdan georgison Portfolio 1
- UserRAPTOR SPRTD 0510081745
- UserBrahmsian's Debt/Equity Por...
- UserBrahmsian's Book Value Port...
- User12 YEAR INVESTOR
Latest RXII Headlines from TheStreet
- Biotech Stock Mailbag: Avanir Pharma 04.01.11 | 07:04 am
- Rodman Rambles: Promising Biotechs 09.15.10 | 10:09 am
- RXi Pharmaceuticals Receives $600,000 Grant 07.13.10 | 10:07 am
- 7 Firms Developing RNAi Drugs 03.30.10 | 06:03 am
- VP Sells $1.6M Worth of Abbott Laboratories 09.28.09 | 11:09 am
Press Releases for RXII
- Emerging Biotech Companies Discuss What’s In The Pipeline At NYSSA Conference - Business Wire 11.10.11 | 10:11 am
- Generex Provides Corporate Update - PR Newswire 08.02.11 | 09:08 am
- RXi Pharmaceuticals Strengthens NeuVax™ (E75) Patent Portfolio - Business Wire 07.13.11 | 07:07 am
- RXi Pharmaceuticals To Present At BIO International Convention - Business Wire 06.24.11 | 07:06 am
- RXi Pharmaceuticals Presents Additional Positive Phase 2 Efficacy Results For Combination Of NeuVaxTM (E75) And Trastuzumab Breast Cancer At ASCO - Business Wire 06.08.11 | 07:06 am
- RXi Pharmaceuticals Announces Positive NeuVaxTM (E75) Phase 2 Efficacy Results After 36 Months Of Follow-Up - Business Wire 06.06.11 | 07:06 am
- RXi Pharmaceuticals Presents Updated NeuVax™ (E75) Data At ASCO - Business Wire 05.19.11 | 07:05 am
- RXi Pharmaceuticals Reports Financial Results For The First Quarter Of 2011 - Business Wire 05.17.11 | 07:05 am
- RXi Pharmaceuticals And The University Of Massachusetts Medical School Announce Massachusetts Life Sciences Center Cooperative Research Grant For RNAi Therapeutics For ALS - Business Wire 04.28.11 | 08:04 am
- RXi Pharmaceuticals Awarded $580,000 In NIH Grants To Advance RNAi Therapeutics - Business Wire 04.26.11 | 09:04 am
Partner Headlines for RXII
- Why CytRx Corporation Is Still A Big Biotech 'If' Play - Seeking Alpha 12.14.11 | 09:12 am
- Buy And Sell Ideas From Yesterday's News Movers - Seeking Alpha 09.30.11 | 09:09 am
- FDA lifts hold on RXi breast cancer vaccine trial - Analyst Blog - Zacks 09.13.11 | 07:09 am
- Gambling With Speculative Healthcare Stocks - Seeking Alpha 09.06.11 | 09:09 am
- RXi Reports Second Quarter Financial Results - Analyst Blog - Zacks 08.19.11 | 09:08 am
- Morning Market Movers - Benzinga 06.06.11 | 09:06 am
- RXi Pharmaceuticals Deal Promises Huge Upside - Seeking Alpha 04.01.11 | 08:04 am
- 18 Stocks on the 52 Week Low List Ready to Pop? - Seeking Alpha 02.12.11 | 09:02 am
- Inside Wall Street: Every January, It's a Four-Day Health Care Fest in San Francisco - AOL 01.21.11 | 12:01 pm
- CytRx: All That Glitters Could be Gold - SeekingAlpha.com 04.20.10 | 06:04 pm
